... Cardiovascular Diseases 11 Chronic KidneyDisease and the Cardiovascular Connection Peter A McCullough and Mohammad Nasser 12 Screening and Diagnosing CardiovascularDisease in Chronic KidneyDisease ... Management of CardiovascularDisease in Chronic KidneyDisease Mohammad Nasser and Peter A McCullough 157 13 14 Cerebrovascular Disease and Chronic KidneyDisease ... Chronic KidneyDisease Stephanie Riggen and Rajiv Agarwal 57 Dyslipidemia and Chronic KidneyDisease Kosaku Nitta 71 Metabolic Acidosis and Chronic Kidney Disease...
... fertilization), are faced with a choice of embryos to implant We are asked to suppose that pre-implantation screening has shown that among the embryos available for implantation are two congenitally ‘deaf’...
... light Of medical science there was little and public sanitation was unknown In consequence dirt and disease were rife in village and town There were no fully equipped hospitals, no trained nurses,...
... patients with axial disease comprise failure to respond to two NSAIDs, bath AS disease activity index (BASDAI) greater than 4, and additional clinical criteria For peripheral joint disease, TNF antagonists ... for spinal disease, more than five inflamed joints, and radiographic erosive changes for peripheral arthritis in any case in which a patient failed to respond to two NSAIDs and two disease- modifying ... (16.7) - Chronic seronegative oligoarthritis 11 (0.2) 35 ± (36.4) 4±3 (40.0) (53.3) (6.7) Crohn's disease arthritis *In years, mean ± standard deviation †p < 0.001 of the difference between rheumatoid...
... aggrecanase activity in different human joint diseases We found greatly increased SF concentrations of aggrecan ARGS fragments in several different joint diseases compared with the healthy knee reference ... be used to monitor aggrecanase activity in joint disease, and to monitor the efficacy of interventions to inhibit this protease activity in joint disease or model systems Competing interests 10 ... 0.026; Figure 3c) The sensitivities of sGAG and aggrecan fragment concentrations as markers for disease were 40% and 32% with specificities of 92% and 91%, respectively (Table 4) We found no significant...
... (SensorMedics Inc, Yorba Linda, CA, USA) found that infants randomized to HFOV had less chronic lung disease compared with infants randomized to CV [10,15] Infants on HFOV in the trial by Gertsmann ... Escobedo MB, Robotham JL, Kuehl TJ: Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation Pediatr Res 1987, 21:594-602 Meredith KS, deLemos ... Winter DC, Taylor A, Clark RH, Null DM: Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons J Appl Physiol 1989, 66:2150-2158 Jackson JC, Truog WE, Standaert TA,...
... increase the supply of organs Furthermore, the organ most likely to be recovered in DCD is the kidney, which will result in significant cost savings to healthcare systems by removing a patient ... 34:1805-1809 Richter S, Yamauchi J, Minor T, Menger MD, Vollmar B: Heparin/phentolamine does not improve kidney perfusion with HTK solution after prolonged warm ischemia in a rat nonheart-beating donor ... 2000, 16 (Suppl):S24-S30 Campbell GM, Sutherland FR: Non-heart-beating organ donors as a source of kidneys for transplantation: a chart review CMAJ 1999, 160:1573-1576 Kowalski AE, Light JA, Ritchie...